Fate Therapeutics Inc Shares Close the Week 27.4% Higher - Weekly Wrap

The company saw its shares close the week 27.4% higher than last week, with trading volume higher than its 30 day average.

Jun 24, 2022 by Kwhen Finance Editors

Fate Therapeutics Inc Shares Close the Week 27.4% Higher - Weekly Wrap
Fate Therapeutics Inc (FATE) shares closed this week 27.4% higher than it did at the end of last week. The stock is currently down 54.2% year-to-date, down 68.4% over the past 12 months, and up 742.8% over the past five years. This week, the Dow Jones Industrial Average rose 2.5%, and the S&P 500 rose 3.6%.

Trading Activity

  • Shares traded as high as $26.86 and as low as $19.55 this week.
  • Shares closed 72.5% below its 52-week high and 56.7% above its 52-week low.
  • Trading volume this week was 36.4% lower than the 10-day average and 20.4% lower than the 30-day average.
  • Beta, a measure of the stock’s volatility relative to the overall market stands at 2.1.

Technical Indicators

  • The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.
  • MACD, a trend-following momentum indicator, indicates an upward trend.
  • The stock closed below its Bollinger band, indicating it may be oversold.

Market Comparative Performance

  • The company's share price beats the S&P 500 Index this week, lags it on a 1-year basis, and beats it on a 5-year basis
  • The company's share price beats the Dow Jones Industrial Average this week, lags it on a 1-year basis, and beats it on a 5-year basis
  • The company share price beats the performance of its peers in the Health Care industry sector this week, lags it on a 1-year basis, and beats it on a 5 year basis
NameDoD %ΔYTD %Δ1 Yr %52-Week H %52-Week L %
Fate Therapeutics Inc4.6-54.2-68.4-73.352.2
Dow Jones Industrial Average2.7-14.8-7.8-15.54.3
S&P 500 Index3.2-19.8-9.3-19.95.3
Health Care1.6-9.21.1-10.68.9

Peer Group Comparative Performance

  • The company's stock price performance year-to-date lags the peer average by 605.9%
  • The company's stock price performance over the past 12 months lags the peer average by 512.7%
NameMKT CAP (USD)P/EYTD %Δ1 Yr %Δ52-Week H %52-Week L %
Fate Therapeutics IncFATE-11.1-54.2-68.4-73.352.2
Peer AvgN/A29.1-7.7-11.2-22.032.6
Becton, Dickinson And Co.BDX39.12.98.7-10.88.6
Neurocrine Biosciences, Inc.NBIX130.414.4-2.9-8.936.9
Sarepta Therapeutics IncSRPT-18.5-16.5-5.6-30.415.0
PTC Therapeutics IncPTCT-5.51.0-8.9-12.260.7
Avidity Biosciences IncRNA0-40.2-47.2-47.841.9

This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.

Was this content valuable for you?

Tags: